Clinical Trial Update: Utility of CC7 Transfer in Stroke Subtypes [NA]

View source ↗

Summary

A clinical trial evaluating the utility of CC7 transfer across ischemic and hemorrhagic stroke subtypes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Stroke
• Spastic Hemiparesis
• Stroke

Drugs mentioned

• CC7 Transfer (CC7 transfer)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Stroke, Ischemic, Stroke Hemorrhagic | NA | Status: RECRUITING